Integrative Liquid Biopsy and Pharmacogenomics for Monitoring Treatment Response and Guiding Precision Therapy in Triple-Negative Breast Cancer: A Mechanistic and Clinical Review
Triple-negative breast cancer (TNBC) is a biologically heterogeneous and clinically aggressive breast cancer subtype in which therapeutic resistance often emerges despite initial chemosensitivity. Conventional tissue biomarkers remain essential for diagnosis and initial treatment selection, but they provide limited inf...